{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Nucleic acid test (NAT)",
      "Transcription-Mediated Amplification (TMA)"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34688036",
  "DateCompleted": {
    "Year": "2021",
    "Month": "12",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "09",
        "Day": "25"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.diagmicrobio.2021.115560",
      "S0732-8893(21)00252-2"
    ],
    "Journal": {
      "ISSN": "1879-0070",
      "JournalIssue": {
        "Volume": "102",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Jan"
        }
      },
      "Title": "Diagnostic microbiology and infectious disease",
      "ISOAbbreviation": "Diagn Microbiol Infect Dis"
    },
    "ArticleTitle": "Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system.",
    "Pagination": {
      "StartPage": "115560",
      "MedlinePgn": "115560"
    },
    "Abstract": {
      "AbstractText": [
        "Testing is crucial in controlling COVID-19. The Procleix\u00ae SARS-CoV-2 assay, a transcription-mediated amplification nucleic acid test that runs on an automated system, was evaluated using inactivated virus and clinical samples. The sensitivity of the assay was assessed using heat-inactivated SARS-CoV-2 and compared to 3 other tests. Clinical validation utilized 2 sets of samples: (1) Nasal, nasopharyngeal and oropharyngeal samples (n\u00a0=\u00a0963) from asymptomatic individuals, and (2) nasopharyngeal samples from symptomatic patients: 100 positive and 100 negative by RT-PCR. The Procleix assay had greater sensitivity (3-fold to 100-fold) than the comparators and had high specificity (100%) in asymptomatic subjects. In symptomatic patients, the Procleix assay detected 100% of PCR-positives and found 24 positives in the initial PCR-negatives. Eighteen of these were confirmed positive and 6 were inconclusive. These studies showed that the Procleix SARS-CoV-2 assay was a sensitive and specific tool for detecting COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 The Authors. Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Catal\u00e0 de la Salut, Barcelona, Spain."
          }
        ],
        "LastName": "Sauleda",
        "ForeName": "Silvia",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Progenika Biopharma, A Grifols company, Derio, Spain."
          }
        ],
        "LastName": "Palacios",
        "ForeName": "Lourdes",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grifols Diagnostic Solutions Inc., San Diego, CA, USA."
          }
        ],
        "LastName": "Br\u00e8s",
        "ForeName": "Vanessa",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain."
          }
        ],
        "LastName": "Pi\u00f1ana",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Progenika Biopharma, A Grifols company, Derio, Spain."
          }
        ],
        "LastName": "Alonso-Hernandez",
        "ForeName": "Lorena",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Catal\u00e0 de la Salut, Barcelona, Spain."
          }
        ],
        "LastName": "Bes",
        "ForeName": "Marta",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Catal\u00e0 de la Salut, Barcelona, Spain."
          }
        ],
        "LastName": "Piron",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Progenika Biopharma, A Grifols company, Derio, Spain."
          }
        ],
        "LastName": "Entrena",
        "ForeName": "Edurne",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grifols Movaco, S.A. Barcelona, Spain."
          }
        ],
        "LastName": "Minguez-Micolau",
        "ForeName": "Antonio M",
        "Initials": "AM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Donostia University Hospital-Biodonostia Health Research Institute, Donostia-San Sebastian, Spain."
          }
        ],
        "LastName": "Marim\u00f3n",
        "ForeName": "Jose Maria",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grifols Diagnostic Solutions Inc., San Diego, CA, USA."
          }
        ],
        "LastName": "Gurrola",
        "ForeName": "Adrian",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Catal\u00e0 de la Salut, Barcelona, Spain."
          }
        ],
        "LastName": "Soria",
        "ForeName": "Gloria",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Catal\u00e0 de la Salut, Barcelona, Spain."
          }
        ],
        "LastName": "Puig",
        "ForeName": "Llu\u00eds",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain."
          }
        ],
        "LastName": "Ant\u00f3n",
        "ForeName": "Andr\u00e9s",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain."
          }
        ],
        "LastName": "Pumarola",
        "ForeName": "Tom\u00e1s",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Grifols Diagnostic Solutions Inc., San Diego, CA, USA. Electronic address: Jeffrey.linnen@grifols.com."
          }
        ],
        "LastName": "Linnen",
        "ForeName": "Jeffrey M",
        "Initials": "JM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Diagn Microbiol Infect Dis",
    "NlmUniqueID": "8305899",
    "ISSNLinking": "0732-8893"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Automation"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "High-Throughput Screening Assays"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Diagnostic Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nucleic Acid Amplification Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ]
}